The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
Glioblastoma (GBM) is the most aggressive primary brain tumor in adults. Despite progress in surgical and medical neuro-oncology, prognosis for GBM patients remains dismal, with a median survival of only 14-15 months. The modest benefit of conventional therapies is due to the presence of GBM stem ce...
Saved in:
Main Authors: | Alessandra Affinito (Author), Cristina Quintavalle (Author), Carla Lucia Esposito (Author), Giuseppina Roscigno (Author), Claudia Vilardo (Author), Silvia Nuzzo (Author), Lucia Ricci-Vitiani (Author), Gabriele De Luca (Author), Roberto Pallini (Author), Anna S. Kichkailo (Author), Ivan N. Lapin (Author), Vittorio de Franciscis (Author), Gerolama Condorelli (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
by: Alessandra Affinito, et al.
Published: (2020) -
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
by: Carla Lucia Esposito, et al.
Published: (2021) -
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
by: Margherita Iaboni, et al.
Published: (2016) -
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
by: Valentina Russo, et al.
Published: (2018) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
by: Carla Lucia Esposito, et al.
Published: (2018)